Insider · CIK 0001690298

Curran Terrie

CIK 0001690298 Name as filed on the most recent filing

Filed as Curran Terrie (14)

17 transaction lines · from 14 filings · filed 2017-09-26 to 2025-01-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

17 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-01-21 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 125,884, disposed Open Form 4 filing 0000950170-25-008348
2024-11-11 S, Open-market sale Arcutis Biotherapeutics, Inc.ARQT 94,238, disposed Open Form 4 filing 0001787306-24-000155
2024-07-15 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 396,699, disposed Open Form 4 filing 0000950170-24-084179
2024-03-22 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 153,513, disposed Open Form 4 filing 0000950170-24-036398
2023-04-06 P, Open-market purchase Phathom Pharmaceuticals, Inc.PHAT 101,025, acquired Open Form 4 filing 0001209191-23-023751
2023-03-01 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 12,265, disposed Open Form 4 filing 0001209191-23-016002
2023-01-20 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 47,729, disposed Open Form 4 filing 0001209191-23-004341
2022-11-21 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 14,650, disposed Open Form 4 filing 0001209191-22-058619
2022-05-13 P, Open-market purchase Phathom Pharmaceuticals, Inc.PHAT 151,835, acquired Open Form 4 filing 0001209191-22-029451
2021-09-09 S, Open-market sale Myovant Sciences Ltd.MYOV 124,063, disposed Open Form 4 filing 0001209191-21-055667
2021-09-02 S, Open-market sale Myovant Sciences Ltd.MYOV 929,489, disposed Open Form 4 filing 0001209191-21-054758
2021-09-01 S, Open-market sale Myovant Sciences Ltd.MYOV 284,325, disposed Open Form 4 filing 0001209191-21-054758
2021-03-22 S, Open-market sale Phathom Pharmaceuticals, Inc.PHAT 2 lines 498,751, disposed Open Form 4 filing 0001209191-21-022705
2019-09-18 S, Open-market sale Celgene Corp /DE/CELG 2 lines 1,114,144, disposed Open Form 4 filing 0001415889-19-001066
2017-09-25 S, Open-market sale Celgene Corp /DE/CELG 248,498, disposed Open Form 4 filing 0001209191-17-053976

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 2
  • Open-market sale 15
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Curran Terrie, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001690298

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.